1. Medtech Insight
  2. >>Policy & Regulation

Medtronic Issues Another Recall For The HeartWare VAD System

 
• By Brian Bossetta

The latest recall for Medtronic's HeartWare Ventricular Assist Device (HVAD) System was triggered by reports of hardened driveline boot covers, which can make disconnecting the driveline from the controller difficult.

Brampton, Ontario, Canada- October 5, 2019: Sign of Medtronic at Canada Headquarters in Brampton, Ontario, Canada. Medtronic is among the world's largest medical equipment development companies.
• Source: Shutterstock

Medtronic has issued yet another recall related to the HeartWare Ventricular Assist Device (HVAD) System System; the issue this time is for hardened driveline boot covers.

In June 2021, Medtronic stopped the sale and distribution of HVAD after a series of serious setbacks. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.